Overview

Biotechnology Venture Capital Investments is an authoritative, insider's perspective on the ins and outs of biotechnology venture capital and the unique factors surrounding venture capital in this ever-evolving industry. Featuring managing directors and partners representing some of the nation's top VC firms, this book provides tactical advice for venture capitalists and entrepreneurs on structuring investments and negotiating deal terms. These industry experts offer proven strategies for establishing valuations, putting together a management team, evaluating risk, and overcoming many of the challenges involved specifically within the biotech industry. From examining term sheets to working with founders, these experts articulate methods for approaching deals strategically and funding appropriately based on key milestones. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great minds powering the biotech venture world, as experts offer up their thoughts around the keys to success within this fascinating industry - where science, investing, and deal-making intersect. Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession, or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book. Chapters include: Building Businesses With Venture Capital by Wm. Blake Winchell, Managing General Partner, Fremont Ventures; Keys to Success: A Vision for Venture Capital in the Biotech Industry by Heidi L. Huntsman, Partner, UV Partners; Strategies for Venture Capital Financing by Thomas L. Churchwell, Managing Partner, ARCH Development Partners LLC; A Random Walk Down Pearl Street by Kyle Lefkoff, General Partner, Boulder Ventures Ltd; Negotiating Points in Venture Capital by Laurence A. Lasky, Ph.D., General Partner, Latterell Venture Partners; A Deal is Just a Deal by Lawrence R. Goldfarb, Chief Executive Officer and Portfolio Manager, LRG Capital Group LLC; A Common Sense Approach to Investing in Biotechnology by Brian H. Dovey, Partner, Domain Associates LLC; and, Taking a Product From Concept to Approval by Harry Ross, M.D., General Partner, Aweida Capital Management. Chapters also include: Strategies for Biotech Venture Investments in Early Stage Companies by Dr. Nelson Teng, Managing Director, Charter Life Sciences; and, Paving the Venture Capital Road to Success in Biotech by Peter N. Allison, Managing Director, Biogenesis Investment Group LLC. Appendices include: Appendix A: Series B Preferred Stock Investment Term Sheet, and, Appendix B: Capital Structure For Company XYZ.

Full Product Details

9781596226449

Table of Contents

Reviews

Author Information

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available